https://boris-portal.unibe.ch/entities/publication/652b7c66-dc7c-418a-94c1-3fcbfec57946
Severe cutaneous toxicity related to Eltrombopag.
severecutaneoustoxicityrelatedeltrombopag
https://adisinsight.springer.com/drugsafety/803923400?error=cookies_not_supported&code=55e09788-c059-4910-9566-af8abb195a65
Eltrombopag/Romiplostim - AdisInsight
Ninety-one adult patients with relapsed or refractory immune thrombocytopenia received eltrombopag or romiplostim and were evaluated for lack of efficacy,
eltrombopagromiplostimadisinsight
https://myhealth.alberta.ca/health/medications/Pages/conditions.aspx?hwid=fdb1158
Eltrombopag - Oral
eltrombopagoral
https://adisinsight.springer.com/drugsafety/803928282?error=cookies_not_supported&code=50972990-a01e-4453-a395-8253de789597
Eltrombopag - AdisInsight
A paediatric patient [age and sex not stated] with chronic immune thrombocytopenia received eltrombopag and experienced isolated thrombosis of dermal
eltrombopagadisinsight
https://adisinsight.springer.com/drugsafety/803811727?error=cookies_not_supported&code=21fc948e-c5b3-454b-b0ae-058d5e9f9d15
Dasatinib/eltrombopag/imatinib - AdisInsight
A 56-year-old woman developed thrombocytopenia during treatment with dasatinib and imatinib for chronic-phase chronic myeloid leukemia (CP-CML). Additionally,
dasatinibeltrombopagimatinibadisinsight
https://adisinsight.springer.com/drugsafety/803793045?error=cookies_not_supported&code=9a9bc92f-9ef0-4176-814d-64015eed0eba
Eltrombopag/prednisolone - AdisInsight
A 44-year-old man developed acute myocardial infarction during treatment with prednisolone, rebound effect in the form of recurrent autoimmune
eltrombopagprednisoloneadisinsight
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed51e463-7a03-4858-bbd2-882ce4753d5a
DailyMed - ALVAIZ- eltrombopag tablet, film coated
dailymedeltrombopagtabletfilmcoated
https://pubmed.ncbi.nlm.nih.gov/41123939/
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES...
ClinicalTrials.gov Identifier: NCT03939637.
for newly diagnosedimmune thrombocytopeniaeltrombopagpediatric
https://adisinsight.springer.com/drugsafety/803927021?error=cookies_not_supported&code=1edd50cf-abe1-4b3e-bb69-0589ff8c3cdd
Eltrombopag - AdisInsight
A patient with immune thrombocytopenia experienced apparent lack of efficacy during treatment with eltrombopag.
eltrombopagadisinsight
https://adisinsight.springer.com/drugsafety/803758768?error=cookies_not_supported&code=6fb89544-5e7f-44c2-b55d-3f080b5d2cbb
Eltrombopag/nivolumab - AdisInsight
A 43-year-old woman developed capillary leak syndrome (CLS) during treatment with nivolumab for nodular stage IIB NRAS-mutated melanoma and eltrombopag for
eltrombopagnivolumabadisinsight